Abbott Laboratories (TSX:ABT)
17.92
-0.17 (-0.94%)
Nov 20, 2026, 4:00 PM EST
Abbott Laboratories Employees
Abbott Laboratories had 115,000 employees as of December 31, 2025. The number of employees increased by 1,000 or 0.88% compared to the previous year.
Employees
115,000
Change (1Y)
1,000
Growth (1Y)
0.88%
Revenue / Employee
595.38K CAD
Profits / Employee
57.74K CAD
Market Cap
255.49B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 115,000 | 1,000 | 0.88% |
| Dec 31, 2024 | 114,000 | 0 | - |
| Dec 31, 2023 | 114,000 | -1,000 | -0.87% |
| Dec 31, 2022 | 115,000 | 2,000 | 1.77% |
| Dec 31, 2021 | 113,000 | 4,000 | 3.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Abbott Laboratories News
- 2 days ago - Abbott begins clinical trial for investigational Encantor system - TheFly
- 2 days ago - Abbott initiates VOYAGER clinical trial for investigational Encantor⢠software-guided balloon-expandable TAVI system to treat aortic stenosis - PRNewsWire
- 2 days ago - Leerink upgrades Abbott to Outperform, raises target to $124 - TheFly
- 2 days ago - Abbott upgraded to Outperform from Market Perform at Leerink - TheFly
- 12 days ago - Abbott price target raised to $125 from $115 at BofA - TheFly
- 17 days ago - These 12 stocks are good bets to beat the 10-year Treasury over the next decade - Market Watch
- 19 days ago - Abbottâs Amulet 360 device shows efficacy in stroke incidence reduction - TheFly
- 19 days ago - Late-breaking one-year data show Abbott's next-generation Amulet 360⢠device continues to demonstrate high rates of left atrial appendage closure and low incidence of stroke - PRNewsWire